abstract |
The invention encompasses the novel class of compounds represented by formula I which are inhibitors of the PTP-1B enzyme. n n n The invention also encompasses pharmaceutical compositions and methods of treating or preventing PTP-1B mediated diseases, including diabetes, obesity, and diabetes-related conditions. |